Syafruddin, Saiful E.
Rodrigues, Paulo
Vojtasova, Erika
Patel, Saroor A.
Zaini, M. Nazhif
Burge, Johanna
Warren, Anne Y.
Stewart, Grant D.
Eisen, Tim
Bihary, Dóra
Samarajiwa, Shamith A. http://orcid.org/0000-0003-1046-0601
Vanharanta, Sakari
Article History
Received: 29 June 2018
Accepted: 15 February 2019
First Online: 11 March 2019
Competing interests
: T.E. is an employee of AstraZeneca on leave of absence from the University of Cambridge, and an author on the study reporting the results from the lenvatinib plus everolimus clinical trial. The remaining authors declare no competing interests.